87 related articles for article (PubMed ID: 9215825)
1. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
McCaffrey JA; Mazumdar M; Bajorin DF; Bosl GJ; Vlamis V; Motzer RJ
J Clin Oncol; 1997 Jul; 15(7):2559-63. PubMed ID: 9215825
[TBL] [Abstract][Full Text] [Related]
2. Ogilvie Syndrome in a Refractory Germ Cell Tumor Treated with Vinblastine, Ifosfamide and Cisplatin Regimen.
Varayathu H; Shah MS; Sarathy V; Thomas BE; Munirathnam V; Shivalingappa SS; Naik R
Case Rep Oncol; 2020; 13(3):1171-1175. PubMed ID: 33173481
[TBL] [Abstract][Full Text] [Related]
3. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.
Loehrer PJ; Gonin R; Nichols CR; Weathers T; Einhorn LH
J Clin Oncol; 1998 Jul; 16(7):2500-4. PubMed ID: 9667270
[TBL] [Abstract][Full Text] [Related]
4. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Al-Ezzi EM; Zahralliyali A; Hansen AR; Hamilton RJ; Crump M; Kuruvilla J; Wood L; Nappi L; Kollmannsberger CK; North SA; Winquist E; Soulières D; Hotte SJ; Jiang DM
Curr Oncol; 2023 Jun; 30(7):6166-6176. PubMed ID: 37504318
[TBL] [Abstract][Full Text] [Related]
5. Second-line therapy in testicular germ cell tumours: results from a tertiary cancer care centre in India.
Joshi A; Kalra D; Simha V; Menon N; Noronha V; Bakshi G; Prakash G; Pal M; Murthy V; Menon S; Sable N; Agrawal A; Rane P; Prabhash K
Ecancermedicalscience; 2022; 16():1408. PubMed ID: 36072230
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario.
Francolini G; Trodella LE; Marvaso G; Matrone F; Nicosia L; Timon G; Ognibene L; Vinciguerra A; Franzese C; Borghetti P; Arcangeli S
Int J Clin Oncol; 2021 Oct; 26(10):1777-1783. PubMed ID: 34273014
[TBL] [Abstract][Full Text] [Related]
7. Current Management of Refractory Germ Cell Tumors.
Abughanimeh O; Teply BA
Curr Oncol Rep; 2021 Jul; 23(9):101. PubMed ID: 34269906
[TBL] [Abstract][Full Text] [Related]
8. The Role of Tumour Metabolism in Cisplatin Resistance.
Wang L; Zhao X; Fu J; Xu W; Yuan J
Front Mol Biosci; 2021; 8():691795. PubMed ID: 34250022
[TBL] [Abstract][Full Text] [Related]
9. Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell Cancers.
Sharma A; Babra DS; Joshi PV; Hall M; Gogbashian A; Vasdev N; Joseph M; Yazdan A; Kanfer E
In Vivo; 2020; 34(6):3675-3679. PubMed ID: 33144484
[TBL] [Abstract][Full Text] [Related]
10. Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors.
Cheriyan SK; Nicholson M; Aydin AM; Azizi M; Peyton CC; Sexton WJ; Gilbert SM
Transl Androl Urol; 2020 Jan; 9(Suppl 1):S45-S55. PubMed ID: 32055485
[TBL] [Abstract][Full Text] [Related]
11. Palonosetron on Days 1 and 5
Shimura Y; Izumi K; Itai S; Iwamoto H; Yaegashi H; Suga Y; Shimada T; Mizokami A; Sai Y
In Vivo; 2019; 33(2):643-647. PubMed ID: 30804153
[TBL] [Abstract][Full Text] [Related]
12. Conventional-Dose versus High-Dose Chemotherapy for Relapsed Germ Cell Tumors.
McHugh DJ; Feldman DR
Adv Urol; 2018; 2018():7272541. PubMed ID: 29736168
[TBL] [Abstract][Full Text] [Related]
13. Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.
Petrelli F; Coinu A; Rosti G; Pedrazzoli P; Barni S
Med Oncol; 2017 Aug; 34(8):133. PubMed ID: 28653284
[TBL] [Abstract][Full Text] [Related]
14. Current Management of Refractory Germ Cell Tumors and Future Directions.
Allen JC; Kirschner A; Scarpato KR; Morgans AK
Curr Oncol Rep; 2017 Feb; 19(2):8. PubMed ID: 28220447
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.
Feldman DR; Hu J; Dorff TB; Lim K; Patil S; Woo KM; Carousso M; Hughes A; Sheinfeld J; Bains M; Daneshmand S; Ketchens C; Bajorin DF; Bosl GJ; Quinn DI; Motzer RJ
J Clin Oncol; 2016 Jul; 34(21):2478-83. PubMed ID: 27185842
[TBL] [Abstract][Full Text] [Related]
16. Robotic Primary RPLND for Stage I Testicular Cancer: a Review of Indications and Outcomes.
Chalfin HJ; Ludwig W; Pierorazio PM; Allaf ME
Curr Urol Rep; 2016 May; 17(5):41. PubMed ID: 26968421
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy.
Kim J; Lee NH; Lee SH; Yoo KH; Sung KW; Koo HH; Seo JM; Lee SK
Korean J Pediatr; 2015 Oct; 58(10):386-91. PubMed ID: 26576183
[TBL] [Abstract][Full Text] [Related]
18. Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.
Selle F; Gligorov J; Richard S; Khalil A; Alexandre I; Avenin D; Provent S; Soares DG; Lotz JP
Braz J Med Biol Res; 2015 Jan; 48(1):13-24. PubMed ID: 25493378
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor.
Kurobe M; Kawai K; Oikawa T; Ichioka D; Kandori S; Takaoka E; Kojima T; Joraku A; Suetomi T; Miyazaki J; Nishiyama H
J Cancer Res Clin Oncol; 2015 Jan; 141(1):127-33. PubMed ID: 25062721
[TBL] [Abstract][Full Text] [Related]
20. First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).
Berger LA; Bokemeyer C; Lorch A; Hentrich M; Kopp HG; Gauler TC; Beyer J; de Wit M; Mayer F; Boehlke I; Oing C; Honecker F; Oechsle K
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1211-20. PubMed ID: 24696231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
